APA-viite

Sosman, J. A., Carrillo, C., Urba, W. J., Flaherty, L., Atkins, M. B., Clark, J. I., . . . Ernstoff, M. S. (2008). Three Phase II Cytokine Working Group Trials of gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2–Positive Advanced Melanoma.

Chicago-tyylinen lähdeviittaus

Sosman, Jeffrey A., et al. Three Phase II Cytokine Working Group Trials of Gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2–Positive Advanced Melanoma. 2008.

MLA-viite

Sosman, Jeffrey A., et al. Three Phase II Cytokine Working Group Trials of Gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2–Positive Advanced Melanoma. 2008.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.